enGene Therapeutics (ENGN) Return on Assets [ROA] (2024 - 2026)
enGene Therapeutics (ENGN) reported Return on Assets [ROA] of -43.76% for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 6.77 percentage points from -36.99% a year earlier and down 4.40 percentage points from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Return on Assets [ROA] (2024 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics posted Return on Assets [ROA] of -44.05%, down 16.35 percentage points from FY2024.
- By fiscal year, Return on Assets [ROA] came in at -27.70% in FY2024 (+152.54 pp) and -180.24% in FY2023.
- Five-year quarterly Return on Assets [ROA] spans a low of -114.44% in fiscal Q1 2024 and a high of -19.08% in fiscal Q4 2024.
- Year over year, Return on Assets [ROA] has now declined in each of the last four quarters, with an average year-over-year change of +9.02 percentage points over the last seven quarters.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -39.36% (Q2 2026), -43.84% (Q1 2026) and -50.23% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | enGene Therapeutics | 104.54 Mn | -889.93 Mn | - | -43.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -43.76% |
| Apr 30, 2026 | -39.36% |
| Jan 31, 2026 | -43.84% |
| Oct 31, 2025 | -50.23% |
| Jul 31, 2025 | -36.99% |
| Apr 30, 2025 | -28.91% |
| Jan 31, 2025 | -23.13% |
| Oct 31, 2024 | -19.08% |
| Jul 31, 2024 | -45.28% |
| Apr 30, 2024 | -61.54% |
| Jan 31, 2024 | -114.44% |
API Access
enGene Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();